Clinical Trial Update: Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from Guangzhou General Hospital investigating the atherogenic effects of uric acid-modified endothelial dysfunction and the preven…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: Guangzhou General Hospital of Guangzhou Military Command | Conditions: Cardiovascular Disease | Phase 4 | Status: UNKNOWN